Sep 21, 2020
Striving for Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer — Faculty Presentation 1: Biomarker assessment in metastatic NSCLC: Predictors of response to targeted therapy and immunotherapy — Dr Govindan. CME information and select publications